These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7563822)
41. [Criteria to hepatitis C treatment response]. Levi D; Tanno H; Descalzi V Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S50-2; discussion S74-82. PubMed ID: 16862861 [No Abstract] [Full Text] [Related]
42. [Antiviral preparations in the therapy of chronic viral hepatitis]. Geller LI Ter Arkh; 1990; 62(11):15-9. PubMed ID: 1710074 [TBL] [Abstract][Full Text] [Related]
43. [Incidence of hepatocellular carcinoma in patients treated with interferon]. Yokosuka O; Omata M Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):805-9. PubMed ID: 7563880 [No Abstract] [Full Text] [Related]
44. Hepatitis C: who should we be treating? Kirchner JT Am Fam Physician; 1999 Jan; 59(2):273-4, 277. PubMed ID: 9930123 [No Abstract] [Full Text] [Related]
45. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same. Herion D; Hoofnagle JH Hepatology; 1997 Mar; 25(3):769-71. PubMed ID: 9049233 [No Abstract] [Full Text] [Related]
46. Should treatment of hepatitis C in HIV-seropositive and HIV-seronegative patients with hemophilia include induction doses of interferon? McGovern B; Bica I Clin Infect Dis; 2003 Aug; 37(3):463-4; author reply 464-5. PubMed ID: 12884180 [No Abstract] [Full Text] [Related]
47. [Antiviral therapy of hepatitis C]. Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250 [TBL] [Abstract][Full Text] [Related]
48. [Selection for treatment of hepatitis C co-infected patients for ]. Findor J; Bessone F; Corti M Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S48-50; discussion S74-82. PubMed ID: 16862860 [No Abstract] [Full Text] [Related]
49. Focus on hepatitis. Increased RBV dose for better HCV treatment response. Bernard EJ IAPAC Mon; 2006 Jan; 12(1):18. PubMed ID: 17249131 [No Abstract] [Full Text] [Related]
55. Does iron reduction improve sustained viral responses to interferon monotherapy in hepatitis C patients? Maybe, but is this the right question? Shedlofsky SI Am J Gastroenterol; 2002 May; 97(5):1093-6. PubMed ID: 12014712 [No Abstract] [Full Text] [Related]
57. Interferon therapy in hepatitis C virus (HCV) induced chronic hepatitis: clinical significance of pretreatment with glycyrhizine. Fujisawa K Trop Gastroenterol; 1991; 12(4):176-9. PubMed ID: 1726032 [No Abstract] [Full Text] [Related]
58. Hepatitis C and pregnancy. Bianca S Aust N Z J Obstet Gynaecol; 2004 Aug; 44(4):375; author reply 375. PubMed ID: 15282023 [No Abstract] [Full Text] [Related]
59. Hepatitis treatment in developing countries. Smeeth L Lancet; 1998 Nov; 352(9141):1711-2. PubMed ID: 9853475 [No Abstract] [Full Text] [Related]
60. Re: Possible prevention of fulminant hepatic failure in four children with acute severe hepatitis. Iorio R; Spagnuolo MI J Gastroenterol; 2005 Sep; 40(9):912; author reply 912-3. PubMed ID: 16211350 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]